Investor Presentation September 2019 Not for promotional use Forward-Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words herein such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "est ...

Insmed, Inc. (NASDAQ:INSM) Q2 2019 Results Conference Call August 1, 2019 8:30 AM ET Company Participants Blaine Davis - Head of Investor Relations Will Lewis - Chairman and Chief Executive Officer Roger Adsett - Chief Commercial Officer John Goll - Chief Accounting Officer Conference Call Participants Martin Auster - Credit Suisse Matthew Harrison - Morgan Stanley Adam Walsh - Stifel Financial Corp Joseph Schwartz - SVB Leerink Josh Schimmer - Evercore ISI Liisa Bayko - JMP Securities Operator Good day, la ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdiction ...

Insmed, Inc. (NASDAQ:INSM) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Blaine Davis - VP & Head of IR William Lewis - President, CEO & Chairman Roger Adsett - Chief Commercial Officer Paolo Tombesi - CFO Conference Call Participants Martin Auster - Crédit Suisse Ritu Baral - Cowen and Company Dewey Steadman - Canaccord Genuity Joseph Schwartz - SVB Leerink Adam Walsh - Stifel, Nicolaus & Company Operator Good day Ladies and gentlemen, and welcome to Insmed Conference Call to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Virginia 54-1972729 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.) (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 IN ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia (State or other jurisdictio ...